Align Technology, Inc. $ALGN Stock Holdings Raised by Invenomic Capital Management LP

Posted by on Jun 18th, 2026

Invenomic Capital Management LP raised its stake in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 15.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 46,610 shares of the medical equipment provider’s stock after purchasing an additional 6,254 shares during the period. Invenomic Capital Management LP owned 0.06% of Align Technology worth $7,278,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Independence Bank of Kentucky increased its position in shares of Align Technology by 77.7% in the 4th quarter. Independence Bank of Kentucky now owns 183 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 80 shares during the last quarter. Miller Global Investments LLC acquired a new position in shares of Align Technology in the 4th quarter valued at about $31,000. JFS Wealth Advisors LLC boosted its holdings in shares of Align Technology by 2,016.7% in the 3rd quarter. JFS Wealth Advisors LLC now owns 254 shares of the medical equipment provider’s stock valued at $32,000 after buying an additional 242 shares during the period. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Align Technology by 1,773.3% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 281 shares of the medical equipment provider’s stock valued at $35,000 after buying an additional 266 shares during the period. Finally, Global Retirement Partners LLC boosted its holdings in shares of Align Technology by 101.8% in the 4th quarter. Global Retirement Partners LLC now owns 230 shares of the medical equipment provider’s stock valued at $36,000 after buying an additional 116 shares during the period. Institutional investors own 88.43% of the company’s stock.

Align Technology Stock Down 3.3%

Align Technology stock opened at $173.53 on Thursday. The firm has a 50-day moving average price of $173.35 and a two-hundred day moving average price of $171.42. The firm has a market capitalization of $12.43 billion, a price-to-earnings ratio of 29.12, a PEG ratio of 1.84 and a beta of 1.67. Align Technology, Inc. has a 52-week low of $122.00 and a 52-week high of $208.30.

Align Technology (NASDAQ:ALGN – Get Free Report) last posted its earnings results on Wednesday, April 29th. The medical equipment provider reported $2.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.26 by $0.32. The firm had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.02 billion. Align Technology had a net margin of 10.50% and a return on equity of 15.82%. Align Technology’s revenue was up 6.2% on a year-over-year basis. During the same period in the previous year, the business posted $2.13 EPS. Research analysts expect that Align Technology, Inc. will post 9.48 earnings per share for the current year.

Align Technology declared that its board has initiated a share repurchase plan on Wednesday, April 29th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to purchase up to 1.6% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s leadership believes its stock is undervalued.

Analysts Set New Price Targets

ALGN has been the subject of several research reports. Evercore lifted their price target on shares of Align Technology from $200.00 to $220.00 in a report on Thursday, April 30th. Weiss Ratings lowered shares of Align Technology from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday, June 4th. Morgan Stanley lifted their price target on shares of Align Technology from $169.00 to $188.00 and gave the company an “equal weight” rating in a report on Friday, April 24th. Leerink Partners lifted their price target on shares of Align Technology from $225.00 to $230.00 in a report on Thursday, April 30th. Finally, Piper Sandler lifted their price target on shares of Align Technology from $220.00 to $235.00 and gave the company an “overweight” rating in a report on Tuesday, April 21st. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $205.85.

Get Our Latest Research Report on Align Technology

About Align Technology

(Free Report)

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.

Featured Articles

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.